Your browser doesn't support javascript.
loading
Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma.
Fujisawa, M; Sakata-Yanagimoto, M; Nishizawa, S; Komori, D; Gershon, P; Kiryu, M; Tanzima, S; Fukumoto, K; Enami, T; Muratani, M; Yoshida, K; Ogawa, S; Matsue, K; Nakamura, N; Takeuchi, K; Izutsu, K; Fujimoto, K; Teshima, T; Miyoshi, H; Gaulard, P; Ohshima, K; Chiba, S.
Afiliação
  • Fujisawa M; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
  • Sakata-Yanagimoto M; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
  • Nishizawa S; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Komori D; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan.
  • Gershon P; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
  • Kiryu M; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
  • Tanzima S; Department of Molecular Biology and Biochemistry, UC-Irvine, Irvine, CA, USA.
  • Fukumoto K; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
  • Enami T; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
  • Muratani M; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
  • Yoshida K; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
  • Ogawa S; Department of Genome Biology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Matsue K; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Nakamura N; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Takeuchi K; Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, Japan.
  • Izutsu K; Department of Pathology, Tokai University School of Medicine, Isehara, Japan.
  • Fujimoto K; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Teshima T; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Miyoshi H; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
  • Gaulard P; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Ohshima K; Department of Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Chiba S; Department of Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Leukemia ; 32(3): 694-702, 2018 03.
Article em En | MEDLINE | ID: mdl-28832024
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Linfoma de Células T / Proteína rhoA de Ligação ao GTP / Proteínas Proto-Oncogênicas c-vav / Linfadenopatia Imunoblástica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Linfoma de Células T / Proteína rhoA de Ligação ao GTP / Proteínas Proto-Oncogênicas c-vav / Linfadenopatia Imunoblástica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão